Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Bentley Pharmaceuticals Reports Record Revenues in Second Quarter of 2004 - Conference call and webcast to be held today at 10:00 A.M. (EDT) - EXETER, N.H., July 28 /PRNewswire-FirstCall/...
Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004 EXETER, N.H., July 21 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals...
Bentley Pharmaceuticals Receives Approval to Market Generic Versions of the Gastrointestinal Product, Lansoprazole, in Spain - Launch Planned for Second Half of 2004 - EXETER, N.H., June 21...
Bentley Pharmaceuticals Elects Two New Directors and Adjourns Annual Stockholders' Meeting EXETER, N.H., June 8 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. (NYSE:BNT), a specialty...
Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference EXETER, N.H., May 24 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. , a specialty...
Bentley Pharmaceuticals Receives Approval to Market a Generic Version of Simvastatin in The U.K. EXETER, N.H., May 18 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. , a specialty...
Bentley Pharmaceuticals Begins Trading on the New York Stock Exchange - Shares continue trading under the ticker symbol 'BNT' - EXETER, N.H., May 12 /PRNewswire-FirstCall/ -- Bentley...
RNS Number:5887U Basepoint PLC 23 January 2004 Basepoint plc Basepoint plc Commences Work on latest Enterprise Centre Basepoint plc has announced that work has begun on the construction...
RNS Number:5495U Basepoint PLC 22 January 2004 BASEPOINT PLC 22 January 2004 DIRECTOR SHAREHOLDING Basepoint plc ("the Company") The Company was advised today that on 21 January...
RNS Number:2172U Basepoint PLC 14 January 2004 BASEPOINT PLC Share Purchase Basepoint plc ("the Company") The Company has today received notification from ACG Developments Limited...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.08 | -2.51846470517 | 82.59 | 84.04 | 77.75 | 27758 | 79.86453038 | CS |
| 4 | 3.51 | 4.55844155844 | 77 | 84.04 | 73.21 | 24464 | 78.18540265 | CS |
| 12 | 16.38 | 25.5418680805 | 64.13 | 84.04 | 62.56 | 22810 | 74.26073548 | CS |
| 26 | 16.38 | 25.5418680805 | 64.13 | 84.04 | 62.56 | 22810 | 74.26073548 | CS |
| 52 | 16.38 | 25.5418680805 | 64.13 | 84.04 | 62.56 | 22810 | 74.26073548 | CS |
| 156 | 16.38 | 25.5418680805 | 64.13 | 84.04 | 62.56 | 22810 | 74.26073548 | CS |
| 260 | 16.38 | 25.5418680805 | 64.13 | 84.04 | 62.56 | 22810 | 74.26073548 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
